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ANTIGEN PRESENTATION BY HAPTEN-SPECIF IC  
B LYMPHOCYTES 
I. Role of  Surface Immunoglobul in Receptors 
BY KENNETH L. ROCK, BARUJ BENACERRAF, AND ABUL K. ABBAS 
From the Departments ofPathology, Harvard Medical School and Brigham and Women's 
Hospital, Boston, Massachusetts 02115 
Cells of the monocyte/macrophage lin age, dendritic cells, and a variety of 
other cell types that express class II histocompatibility (Ia) molecules on their 
surfaces are capable of presenting foreign protein antigens to and stimulating Ia- 
restricted inducer (helper) T lymphocytes (1-3). After the demonstration that B 
cells also bear Ia antigens (4) and that at least some interactions between antigen- 
specific helper T cells and B lymphocytes are Ia restricted (5), many investigators 
have attempted todetermine whether B lymphocytes can also function as antigen- 
presenting cells. Among the earliest studies to demonstrate hat B cells can, in 
fact, present antigens to T cells were the experiments showing that macrophage- 
depleted murine B cells incubated with protein antigens could stimulate immune 
T lymphocytes to proliferate in an Ia-restricted fashion (3). More convincing 
evidence for the role of B cells in presenting antigen came from studies of 
Chesnut and Grey (6), who showed that macrophage-depleted splenocytes cul- 
tured with rabbit anti-mouse immunoglobulin (Ig), but not rabbit IgG lacking 
anti-Ig activity, could stimulate rabbit 3,-globulin-primed T cells to proliferate in 
vitro (6). This result not only established the ability of B lymphocytes to present 
protein antigens to T cells but also indicated that their surface Ig receptors 
played an important role in this phenomenon. Subsequently, it has been shown 
that resting and mitogen-activated normal B lymphocytes a  well as a variety of 
Ia-positive B cell-derived tumors and cell lines are capable of presenting foreign 
proteins to Ia-restricted, antigen-reactive T lymphocytes (7-12). In all these 
situations, high concentrations of antigens are required and surface Ig receptors 
play no role. In fact, the amounts of antigens required for such presentation are 
comparable to those observed with other accessory cells (1, 2), but in vast excess 
of the concentrations required for T cell-dependent, antigen-specific, major 
histocompatibility-restricted activation of primed B lymphocytes (13). Thus, 
although cloned B cell tumors and normal B lymphocytes are valuable for 
analyzing the cellular and molecular events in antigen presentation (e.g., 14, 15), 
the relevance of such studies to physiologic antigen-specific T-B interactions 
involving cognate recognition of linked antigenic determinants is unclear. 
In an attempt o develop systems for analyzing the interactions between 
antigen-specific T and B lymphocytes, we have investigated the ability of B cells 
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enriched for expression of surface receptors for a defined hapten to present 
hapten-protein to carrier-specific T cells. In the initial experiments, primed 
murine B lymphocytes specific for 2,4,6-trinitrophenyl (TNP) 1 were used to 
present a TNP-modified, Ir gene-controlled synthetic terpolymer of glutamic 
acid, lysine, and phenylalanine (GLib) to a GLib-reactive T cell hybridoma. Such 
cloned hybridoma cells, which secrete interleukin 2 (IL-2) upon interaction with 
the relevant nominal antigen and Ia determinant, have been extensively charac- 
terized and are widely used to analyze the requirements for T cell activation 
(16-17). Our experiments demonstrate that hapten-specific B lymphocytes are 
highly efficient at presenting hapten-protein to T cells, and that hapten-binding 
surface Ig molecules are critically involved in this effective form of T-B interac- 
tion. Moreover, in this system it appears that the major role of surface Ig is to 
concentrate or "focus" antigen on to relevant B cells such that very low concen- 
trations of antigen are able to maximally stimulate the responding T lymphocytes. 
The results also raise the possibility that antigen-binding B cells may serve an 
important role as antigen-presenting cells in physiologic immune responses. 
Materials and  Methods  
Mice. BALB/c mice, ages 6-12 wk, were purchased from Charles River Breeding 
Laboratories, Inc., Kingston, NY or Cumberland Farms, Clinton, TN. Animals used in 
this study were maintained inaccordance with the guidelines of the Committee on Animals 
of the Harvard Medical School and those prepared by the Committee on Care and Use 
of Laboratory Animals of the Institute of Laboratory Animal Resources, National Re- 
search Council (DHEW Publication No. (NIH) 78-23, revised 1978). 
Antigens and Antibodies. Hapten conjugates of GL4~, keyhole limpet hemocyanin 
(KLH), human serum albumin (HSA), bovine 3~-globulin (BGG), and lipopolysaccharide 
(LPS) were prepared by incubating the carriers with 2,4,6-trinitrobenzene sulfonic acid 
(TNBS) at pH 9-9.5 for 4-6 h, and removing unbound TNBS by dialysis or gel filtration. 
Rabbit anti-mouse Ig was prepared from a hyperimmune rabbit anti-mouse F(ab')2 
serum by affinity chromatography on mouse 3,-globulin-coupled Sepharose 4B, digested 
with pepsin, and the F(ab')2 fragment purified by passage over protein A-Sepharose. A 
control normal rabbit F(ab')2 was prepared from rabbit serum absorbed with mouse 3,- 
globulin. The following anti-TNP mouse sera were used: hyperimmune BALB/c anti- 
TNP-KLH serum and sera from mice immunized 2-6 wk previously with TNP-KLH in 
complete Freund's adjuvant and used as donors for B cells (see below). All these sera were 
heat inactivated and shown to have TNP binding activity at dilutions > 1:106 in a sensitive, 
solid phase radioimmunoassay using TNP-bovine albumin-coated microtiter plates. In 
addition, two monoclonal anti-TNP antibodies were used: an IgGl,x (termed HDPI; 
provided by Dr. H. Urnovitz and Dr. R. Lynch, University of Iowa) and an IgM,~ (termed 
T2.8), prepared by fusion of TNP-Ficoll-immunized BALB/c spleen cells. Both of these 
showed anti-TNP activity at titers >1:102 in the solid phase radioimmunoassay. The 
following monoclonal anti-Ia antibodies were used in blocking experiments at a 1:8 
dilution of hybridoma culture supernatant: MKD6 (18) (anti-I-A a) and 14.4.4s (19) (anti- 
I-Ed). 
Hapten-specific B Lymphocytes. Spleen cells were obtained from BALB/c mice immu- 
nized 6 d previously with 0.5 ~g of TNP-LPS in aqueous olution intraperitoneally (i.p.) 
1 Abbreviations used in this paper: BGG, bovine 3,-globulin; GAT, random terpolymer of glutamic 
60 30 10 56 $5 acid , alanine , and tyrosine ; GLqS, random terpolymer of glutamic acid , lysine , and 
phenylalanineg; HSA, human serum albumin; IL-2, interleukin 2; KLH, keyhole limpet hemocyanin; 
LPS, E. coli lipopolysaccharide; MEM, minimum essential medium with 5% heat-inactivated fetal calf 
serum; MHC, major histocompatibility complex; TNBS, 2,4,6-trinitrobenzene sulfonic acid; TNP, 
2,4,6-trinitrophenyl. 
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or 2-6 wk previously with 100 #g of TNP-KLH in complete Freund's adjuvant i.p. 
Hapten-binding B cells were purified by a modification of the technique of Haas and 
Layton (20). Erythrocyte-free spleen cells were suspended in minimum essential medium 
with 5% heat-inactivated f tal calf serum (MEM) and incubated on 100-mm plastic ulture 
dishes coated with TNP-gelatin, at a ratio of 100-150 X 108 cells in 5 ml per dish. Dishes 
were rocked gently at 4°C for 60 min, washed five times with ice-cold MEM, and bound 
cells eluted by adding 5 ml of MEM warmed to 37°C. Cells were treated with t00 U/ml 
of collagenase (Worthington Biochemical Corp., Freehold, NJ) for 15 min at 37°C to 
remove bound TNP-gelatin, washed three times, and viable cell recovery determined by 
trypan blue dye exclusion. In our hands, 0.5-1.5% of input splenocytes were recovered 
from TNP-gelatin dishes; 50% of these cells expressed surface Ig by immunofluorescence 
and 20-40% have detectable TNP receptors as determined by rosette assays with TNP- 
coupled sheep erythrocytes. Both these assays may underestimate the number of hapten- 
specific ells because of receptor modulation during the purification procedure. After 4 
d stimulation with LPS in vitro, the TNP-gelatin-enriched cells show a 50-100-fold 
enrichment of anti-TNP antibody-secreting cellprecursors (on a per cell basis) compared 
with the initial, unpurified splenocyte population. The cells eluted from hapten-gelatin 
are referred to as hapten-specific B lymphocytes in the following sections. 
T Cell Hybridomas. RF21.21.9 was obtained from the fusion of BALB/c GL~immune, 
antigen-restimulated, proliferating T cells to the AKR thymic lymphoma, BW 5147, as 
previously described (17). It produces IL-2 when stimulated with GLib in association with 
I-E d. This response is exquisitely antigen specific and H-2 restricted (K. L. Rock and B. 
Benacerraf, manuscript in preparation). RF7.24.3 is a BALB/c, I-A n + GAT-specific, IL- 
2-producing T cell hybridoma that was similarly derived (21). 
Cell Culture and Assay Conditions. Culture media was RPMI 1640 (M. A. Bioproducts, 
Walkersville, MD) supplemented as previously described (21). 5-7.5 × 104 T cell hybri- 
domas were cultured in 200-#1 flat-bottom icrocuitures with or without accessory cells, 
in the presence or absence of antigen and in some cases antibody. The source of accessory 
cells was either hapten-specific, unirradiated B cells, irradiated (1,600 rad) or unirradiated 
whole spleen cells, or the in vitro passaged, cloned B lymphoblastoid tumor, A20.2J (16). 
The precise numbers of accessory cells and the concentration f antigen or antibody are 
detailed in the respective experimental protocols. After 18-24 h incubation at 37 ° C, 100 
~tl of culture supernatant was removed, exposed to 8,000 rad gamma irradiation, and 
assayed for IL-2 content. IL-2 was measured by quantitating the incorporation of [3H]- 
thymidine into DNA of an IL-2-dependent T cell line, HT-2, in response to this lympho- 
kine (I 8, 21). Data are expressed as the arithmetic mean counts per minute of duplicate 
cultures. 
Results 
Presentation of Hapten-modified Antigen by Hapten-specific B Cells. In the first 
series of  experiments we compared the ability of TNP-specific BALB/c (H-2 d) B 
lymphocytes to present GLib and TNP-modif ied GL~ to the GLC~-specific, I-E d- 
restricted T cell hybridoma, RF21.21.9. As shown in Fig. 1, such hapten-specific 
B lymphocytes were capable of presenting the TNP-protein at a <10-fold lower 
concentration than the unmodif ied protein. A more detailed analysis of  the 
antigen concentrations and presenting cell numbers required to activate the T 
cell hybridoma is shown in Figs. 2 and 3. Hapten-specific B cells presented TNP-  
GL~ at concentrations as low as 0.1 #g/ml, and as few as 7 × 10 s cells were 
effective at presenting haptenated protein. It is noteworthy that with 2 × 105 
TNP-specific B cells, TNP-GL~ at 0.1 #g/ml, which is the lowest concentration 
we have tested, produced >70% of the maximal T cell response (Fig. 2). In 
contrast, the same B cells presented unmodified GLib only at high concentrations 
(100 #g/ml) and relatively high cell numbers (2 x 105). Thus, hapten-specific B 
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FIGURE 1. Comparison of hapten-specific B cell antigen presentation of native and hapten- 
conjugated GL~. Microcultures were prepared with 5 x 104 RF21.21.9 T cell hybrid and 6 x 
105 TNP-binding B cells in the presence or absence of indicated amount of antigen (O, TNP- 
GLq~; Q, GL4~) in 200 t~l. After 18 h incubation, 100 #1 of culture supernatant was removed, 
irradiated, and assayed for IL-2 content. Control experiments have shown no detectable IL-2 
in cultures of B cells plus antigen, in the absence of specific T cell hybrids (data not shown). 
Hapten-specific B cells were isolated from TNP-LPS-primed mice. 
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FIGURE 2. Comparison of hapten-conjugated antigen presentation by antigen-specific and 
naive B cells. Microcultures were prepared as described in Fig. 1 except hat the source of 
antigen-presenting cells was varied: (A) 2 × 105 TNP-binding B cells from TNP-LPS-primed 
mice; (B) 105 A20 B-lymphoblastoid cells ( ) or 2 × 10~unirradiated, naive splenocytes 
(_ _ _). Both A and B are from the same experiment. 
cells presented the haptenated antigen >l,000-fold more efficiently than the 
unmodified antigen. This effect was hapten specific, since GL4~ modified with 
other haptens, such as fluorescein, was presented by TNP-specific B cells like the 
unhaptenated protein (data not shown). Moreover, TNP-GL4~ was not intrinsi- 
cally more immunogenic than GL4~, as both A20.2J B lymphoma cells and naive, 
unpurified splenocytes (Fig. 2) showed no difference in their ability to present 
the two antigens. Both of these accessory cell populations required high concen- 
trations of antigen (10-100 ~g/mi), which was precisely the concentration of
unhaptenated antigen required by hapten-specific B ells (Figs. 1 and 2). Controls 
done with these and subsequent experiments showed that in the absence of either 
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FIGURE 3. Titration of the number of TNP-specific Bcells required for antigen presentation. 
Microcultures were prepared as described in Fig. 1, with the indicated number of TNP- 
binding B cells and the presence orabsence ofthe indicated concentration f TNP-GL~. This 
data was obtained from the same xperiment illustrated inFig. 9. 
antigens or presenting cells, the T cell hybridoma was not stimulated to produce 
IL-2. Furthermore, the hapten-specific B ceils alone did not produce IL-2 upon 
challenge with TNP-GL4~ or GEqL as expected (data not shown). Identical results 
were obtained with B cells from TNP-LPS- and TNP-KLH-primed mice. 
I-E Restriction of Antigen Presentation by B Lymphocytes. Monoclonal antibody 
blocking experiments were done to determine the major histocompatibility 
complex (MHC) restriction of antigen presentation by hapten-specific B cells. As 
shown in Table I, stimulation of the I-Ed-restricted T cell hybridoma by 
BALB/c TNP-specific B cells and TNP-GL~b was markedly inhibited by mono- 
clonal anti-LE d relative to anti-I-A d antibody. This effect was specific, since both 
antibodies bind to the presenting cells, and the reciprocal pattern of inhibition 
was observed with I-An-restricted T cell hybridomas. The same pattern of 
inhibition was seen with either TNP-specific B lymphocytes or A20.2J cells and 
high concentrations of unmodified GLq~ (data not shown). 
Role of Hapten-binding I  Receptors in Antigen Presentation. The above exper- 
iments indicated that cell populations enriched for hapten-specific B iymphocytes 
were also markedly and selectively enriched for cells capable of presenting 
hapten-modified proteins to Ia-restricted T cells. To establish a role for surface 
Ig in this phenomenon, attempts were made to block antigen presentation with 
ligands that would be expected to bind to receptors for the hapten. As shown in 
Table II, preincubation of TNP-specific B cells with affinity-purified rabbit anti- 
mouse Ig completely blocked the ability of these cells to present TNP-GL4~ to 
the T cell hybridoma, RF21.21.9, and TNP-conjugated HSA or BGG inhibited 
the presentation of TNP-GL4~ by 80-90%. Unhaptenated proteins (Table II) or 
rabbit Ig (data not shown) had no effect. This inhibition was highly specific, since 
the anti-Ig and TNP-proteins did not interfere with the ability of the same TNP- 
specific B cells to present GLq~ at high concentrations, despite the response being 
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TABLE I 
Effect of Monoclonal a-Ia Antibody on Antigen Presentation of TNP- 
GL~ 
2 × l05 TNP- Monoclonal 
Hybrid B cells Antigen antibody cpm 
RF21.21.9 
RF7.24.3 
tag/ml 
+ --  - -  2,981 
+ 10 GLq5 - -  2,564 
+ 1 TNP-GL~ --  35,289 
+ 1 TNP-GLq~ I-E a 4,911 
+ 1 TNP-GLq~ I-A d 15,863 
+ - -  - -  2,722 
+ 100 GAT --  23,964 
+ 100 GAT 1-E a 16,262 
+ 100 GAT I-A a 3,588 
Microcultures were prepared as described inFig. 1, except 2 × 105 TNP- 
binding B cells were used and a 1:8 dilution of  monoclonal  antibody- 
containing culture supernatant was added where indicated. RF7.24.3 is a 
GAT + I-Aa-specific T cell hybrid included as a reciprocal control. TNP- 
specific ells were obtained from TNP-LPS-primed mice. a-I-E a, 14.4.4.S; 
a-I-A a, MKD6. 
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substantially weaker. Moreover, none of  the inhibitors affected the ability of  
non-TNP-b ind ing A20.2J B cells to present he same antigen, TNP-GL~b (Table 
II). These results demonstrate that the augmented presentation of TNP-protein 
by TNP-binding B cells is specific for the hapten and not the carrier, and directly 
implicate B cell Ig in this highly efficient presentation of  haptenated antigen. 
Function of lg Receptors in Antigen Presentation. There  are several, not mu- 
tually exclusive, reasons why hapten-binding B lymphocytes might be particularly 
efficient at presenting haptenated antigen to Ia-restricted T cells. The  simplest 
is that Ig receptors erve to focus antigen, and perhaps direct its pathway of  
endocytosis and processing. Alternatively, the binding of  antigen to surface 
receptors may deliver a signal(s) that activates target B lymphocytes to become 
more efficient at presenting antigen; such activation events may include enhanced 
expression of  Ia determinants (22-24). To  test this possibility, TNP-specific B 
cells with and without TNP-GLq~ were compared for their ability to stimulate a
T cell hybridoma specific for an unrelated, unmodif ied protein, GAT (a ter- 
polymer of  glutamic acid 66, alanine s°, and tyrosine ~0), or to stimulate an alloreac- 
tive T cell hybridoma. As shown in Table III, the continuous presence of TNP-  
GL4~ at a concentration at which it was effectively presented id not alter the 
ability of  TNP-specific B cells to present GAT to a GAT + I-Ad-specific T cell 
hybridoma. Similarly, TNP-GL4~ did not make the TNP-specific B cells more 
efficient stimulators of  an allogeneic I-Ea-reactive T cell hybridoma. This is 
particularly relevant since I-E a is the restriction element of  the GL~-reactive 
hybrid, RF21.21.9. Finally, the presence of  TNP-conjugated HSA or BGG did 
not activate the hapten-specific B cells to more efficiently present unmodif ied 
GL4~ to RF21.21.9, as they would TNP-GL~b (Table II). Therefore,  the interac- 
tion of  TNP-conjugated antigens with the B cells fails to markedly enhance their 
ability to present unhaptenated antigens in a noncognate manner. 
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TABLE II 
Hapten- and Immunoglobulin-specific Blo king of TNP-GL¢~ Presentation by Specific B Cells 
Antigen-present- Antigen (#g/ml) Inhibiting antigen/ cpm Percent 
Hybrid ing cells Ab (#g/ml) inhibition 
RF21.21.9 2 x 105 TNP-B - -  - -  1,051 
2 X 105 TNP-B 0.3 TNP-GL4~ - -  49,206 
50 RAMG F(ab')~ 1,257 100 
10O TNP-HSA 7,428 88 
100 HSA 52,768 0 
100 TNP-BGG 8,806 84 
100 BGG 48,781 1 
2 x 105 TNP-B 100 GL~ - -  5,345 
50 RAMG F(ab')2 9,623 0 
100 TNP-HSA 13,054 0 
100 HSA 4,134 28 
100 TNP-BGG 5,356 0 
100 BGG 4,492 20 
2 x 105 TNP-B 
m 
m 
m 
B 
50 RAMG F(ab')2 1,412 
100 TNP-HSA 2,051 
10O HSA 1,305 
100 TNP-BGG 2,198 
100 BGG 1,254 
RF21.21.9 105 A20 1,801 
105 A20 25 TNP-GL4~ - -  68,831 
50 RAMG F(ab')2 66,470 0 
100 TNP-HSA 47,534 31 
100 HSA 58,948 14 
100 TNP-BGG 68,190 0 
100 BGG 77,160 0 
Microcultures were prepared as described in Table I except for the addition of the indicated amount 
of rabbit anti-mouse Ig (RAMG) F(ab')2 or competing antigen. These potential inhibitors were 
incubated with B cells at 37°C for 60 min before the addition of hybrids, and were continuously 
present throughout the remainder of the culture. Data from one representative experiment out of 
two are shown. In the second experiment, RAMG F(ab')~ inhibited presentation f TNP-GL$ by 
TNP-specific B cells by 100%, while normal rabbit F(ab'), had no effects. 
It is possible that TNP-spec i f ic ,  immunized  B lymphocytes  secrete small 
amounts  o f  ant ihapten  ant ibody  that  complexes  with and  augments  the presen-  
tat ion o f  hapten-prote in .  To  test this possibi l ity, A20.2 J  cells were incubated  
with TNP-GL$ at a subopt imal  concent rat ion ,  with and wi thout  a wide range  o f  
d i lut ions o f  four  d i f fe rent  ant i -TNP  ant ibod ies  (two sera and two monoc lona ls  
both  IgG and  IgM),  and  the IL-2 response o f  the RF21.21 .9  hybr idoma mea-  
sured.  None o f  the ant ibod ies  tested a l te red  the presentat ion  o f  TNP-GL$ under  
these condi t ions  (Tab le  IV). 
Discussion 
The experiments reported in this paper were designed to examine the ability 
of antigen-binding B lymphocytes to present the specific antigen to Ia-restricted 
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TABLE I I I  
Haptenated Antigen Does Not Augment Antigen or MHC Molecule Presentation i  a 
Noncognate Manner 
Hybrid specific- TNP-B  cells Antigen (#g/ TNP-GL4~ (1 cpm 
Hybrid ity (× 10 ~) ml) #g/ml) 
RF7.24.3 GAT + I-A d 2 - -  - 2,722 
2 10 GAT - 18,549 
2 1 GAT - 8,047 
2 I GAT  + 5,132 
RF26.12 I-E d (Allo) - -  - -  - 3,486 
1 - -  - 33,840 
0.5 - -  - 31,074 
0.25 - -  - 15,042 
0.125 - -  - 8,064 
0.075 - -  - 5,502 
1 - -  + 36,233 
0.5 - -  + 26,184 
0.25 - -  + 23,129 
0.125 - -  + 10,565 
0.075 - -  + 6,313 
Microcultures were prepared as described in Table I except using the RF7.24.3 and RF26.12 hybrids 
and the corresponding antigen to RF7.24.3, GAT.  Data was obtained for the same exper iment 
illustrated in Table I, demonstrat ing that 1 #g/ml  of  TNP-GLq~ was presented strongly in a cognate 
manner.  
TABLE IV 
Anti-TNP Antibody Does Not Enhance the Presentation of TNP-GL4~ 
Antigen-present- Antigen (~g/ml) Antibody* cpm 
Hybrid ing cells 
RF21.21.9 TNP-B  cell - -  - -  312 
10 GLq~ - -  268 
1 TN P-GL4~ - -  9,299 
A20 
100 TNP-GLq~ 
33 TNP-GL~ 
10 TNP-GLq~ 
1 TNP-GLf f  
A20 1 TNP-GLO 
- -  347 
- -  13,520 
- -  1,782 
- -  343 
- -  1,046 
1:10 -4 hyper immune serum 816 
I:10 -5 byper immune serum 669 
1:10 -3 donor  serum 638 
1:10  -s donor  serum 693 
1:4 T2.8 MAb 964 
1:8 T2.8  MAb 871 
1:4 HDPx MAb 627 
1:8  HDPI MAb 633 
Microcultures were prepared as described in Table I except hat either 2.5 × 10 ~ TNP-B  cells f rom 
TNP-KLH-pr imed mice or 5 × 104 A20 cells were used and the indicated source of  ant i -TNP 
antibody was added. 
* Donor serum was serum obtained from the immune B cell donors. MAb, monoclonal antibody. 
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T cells. Using a model system in which TNP-primed B lymphocytes, enriched 
for hapten-binding cells, were used to present a TNP-modified protein, GL~, to 
a GL¢-reactive, I-Ed-restricted T cell hybridoma, we have observed that such B 
cells are remarkably efficient antigen-presenting cells. Hapten-specific B lympho- 
cytes were capable of activating the T cell hybridoma in the presence of soluble 
hapten-protein at 100 ng/ml, which is a lower antigen concentration for effective 
presentation to T cells than has been described in any in vitro system, to date. 
Moreover, as few as 7 × l0 s hapten-enriched cells were sufficient o stimulate 
the relevant T cell hybridoma. Considering the low numbers of hapten-specific 
B lymphocytes that are effective at presenting antigen, it is likely that these cells 
alone are sufficient for stimulating the T cell response. Recent experiments 
(work in progress) using transformed, antigen-specific B cell clones support his 
interpretation. However, it should be pointed out that the question of whether 
other cell types present in the hapten-enriched population also play a role in 
activating T lymphocytes has not been addressed by our experiments. 
Several lines of evidence demonstrated a central role of surface Ig in the 
presentation of hapten-protein by hapten-specific B cells. First, TNP-specific B 
cells presented low concentrations of TNP-GLq~ but not unmodified GL¢ (Fig. 
2) or fluorescein-conjugated GL4~ (not shown) to the same GL¢-reactive T cell 
hybridoma. Second, the presentation of TNP-GL4~ by the B cells was specifically 
inhibited by anti-lg antibody and by other TNP-modified proteins (Table II). In 
this respect, our observations are fundamentally different from most results of 
antigen presentation by B lymphocytes. Thus, resting, activated, and neoplastic 
B cells are capable of presenting protein antigens to Ia-restricted T cells (6-12), 
but in all these cases Ig receptors play no role. The only situation in which a 
function for B cell Ig in antigen presentation has been demonstrated is the study 
of Chesnut and Grey (6) showing that rabbit anti-Ig is presented by partially 
purified B cell populations under conditions where normal rabbit Ig is not. Even 
in these experiments, however, high concentrations of protein antigen were 
required, comparable to the concentrations at which effective presentation is 
observed with other accessory cells such as macrophages and dendritic ells. 
It has been postulated that Ig receptors on B lymphocytes may serve at least 
two functions relevant o the ability of these cells to present antigens to T cells. 
The most obvious is that receptors focus antigen on the cell surface and lead to 
a sequence of endocytosis and processing that culminates in the expression of 
antigenic determinants in association with Ia molecules. In addition, the antigen- 
receptor interaction may activate B cells to a state at which they are efficient at 
antigen presentation; such activation may include enhanced expression of Ia, 
more efficient antigen processing, and other, as yet undefined, changes in the 
physiologic properties of the cells (22-24). In our experiments, TNP-GL¢ did 
not enhance the ability of TNP-specific B cells to present an unrelated, nonhap- 
tenated protein or to stimulate alloreactive T cell hybridomas (Table III), and 
the enhanced presentation always required linked or cognate recognition of 
hapten-carriers by carrier-specific T cell hybridomas. Moreover, there was no 
evidence that antibody secretion could account for the ability of these cells to 
present TNP-protein (Table IV). Therefore, by exclusion, it is likely that the 
only or major role of surface Ig in antigen presentation by B cells is to bind and 
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focus the specific antigen. It should be emphasized that the B cells used in the 
present experiments were obtained from primed animals and were, therefore, 
previously activated. It is certainly conceivable that in resting B cells, the 
activation induced by antigen-receptor interactions plays a more important or 
readily demonstrable role in antigen presentation. In any event, it is likely that 
antigen binds to surface Ig and is endocytosed and degraded by proteolytic 
enzymes; such a sequence of events has been demonstrated with anti-Ig antibodies 
(25). Thus, in general, the cellular processes leading to Ia-associated antigen 
presentation may be similar in B lymphocytes and in more intensively studied 
antigen-presenting ceils, such as monocytes/macrophages and possibly dendritic 
cells (1, 2). 
The ability of B cells to present nominal protein antigens to inducer T cells 
has several implications for physiologic immune responses. It may provide an 
accessory cell-independent mechanism for stimulating inducer cells to secrete 
helper factors that are necessary for clonal expansion and differentiation of B 
lymphocytes. The critical role of surface Ig in this phenomenon suggests that B 
cells are most efficient at presenting the antigen for which they express pecific 
membrane receptors. This provides an explanation for the observation that 
physiologic ognate T-B collaboration occurs at concentrations of antigens that 
are insufficient to cause detectable activation of helper T cells in conventional in
vitro assays for DNA synthesis in which antigen is presented by macrophages or
dendritic cells. Furthermore, it would account for the finding that in most 
antibody responses in vivo, activation of bystander B cells is rarely or never 
observed. This may also explain, at least in part, the stringent MHC restriction 
of T-B interactions observed in vivo and in secondary antibody responses to low 
dose antigen challenge in vitro (5, 26). 
Finally, our finding that B cells present antigens at concentrations approaching 
expected physiologic levels suggests that such cells may play a major role in 
presenting antigen, at least to previously activated T lymphocytes, in vivo. 
Whether, in addition to this ability to present antigen in association with Ia 
molecules, B cells produce secondary activation signals, e.g., interleukin 1, is not 
known (17). Such antigen-nonspecific cytokines may be important for the acti- 
vation of naive or resting T lymphocytes. Thus, it remains to be determined 
whether or not B lymphocytes are also capable of initiating antigen-specific 
immune responses, i.e., by stimulating normal, resting inducer T cells. 
Summary  
The present study examines the ability of hapten-specific murine splenic B 
lymphocytes to present hapten-proteins to carrier-specific T cell hybridomas. 
BALB/c B cells specific for 2,4,6-trinitrophenyl (TNP) were isolated from spleens 
of immune mice by elution from TNP-gelatin-coated dishes. Such cells presented 
the TNP-modified terpolymer, GL4~, at concentrations a low as 0.1 /~g/ml, to a 
GL4~-specific, I-Ed-restricted, interleukin 2-producing T cell hybridoma. In 
contrast, the same B lymphocytes required 1,000-fold higher concentrations of
unmodified GLq~ to stimulate the same T cell hybridoma. The presentation of 
low concentrations of TNP-GLq~ by TNP-specific B lymphocytes was significantly 
or completely blocked by anti-Ig antibody or TNP-proteins, indicating that 
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surface Ig receptors were critically involved in this phenomenon. Finally, binding 
of TNP-proteins did not alter the ability of  the B cells to present unrelated, 
unhaptenated proteins or to stimulate alloreactive T cells. These results suggest 
that surface Ig receptors erve to focus antigens onto specific B lymphocytes and 
that such cells are highly efficient at presenting linked antigenic determinants o
T cells. The  implications of  these findings for the mechanisms of  physiologic, 
histocompatibility-restricted T-B collaboration are discussed. 
We thank Mary LoGiudice for invaluable secretarial assistance and Dr. P. S. Pillai, 
University of Rochester, for his gifts of hapten-gelatin. 
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